vs
Side-by-side financial comparison of Enhabit, Inc. (EHAB) and STURM RUGER & CO INC (RGR). Click either name above to swap in a different company.
Enhabit, Inc. is the larger business by last-quarter revenue ($270.4M vs $151.1M, roughly 1.8× STURM RUGER & CO INC). On growth, Enhabit, Inc. posted the faster year-over-year revenue change (4.7% vs 3.6%). STURM RUGER & CO INC produced more free cash flow last quarter ($12.3M vs $3.3M). Over the past eight quarters, STURM RUGER & CO INC's revenue compounded faster (5.1% CAGR vs 1.5%).
Enhabit, Inc., is a Dallas, Texas-based provider of home health and hospice services. The company operates 255 home health and 110 hospice locations in 34 states with a concentration in Texas, Alabama, Florida, Georgia, Oklahoma and Mississippi. Enhabit is the fourth-largest provider of home health services in the United States and is a leading provider of hospice services. The company was formed in 2022 when Encompass Health spun off its home health and hospice business.
Sturm, Ruger & Company, Inc., better known by the shortened name Ruger, is an American firearm manufacturing company based in Southport, Connecticut, with production facilities also in Newport, New Hampshire; Mayodan, North Carolina; and Prescott, Arizona. The company was founded in 1949 by Alexander McCormick Sturm and William B. Ruger and has been publicly traded since 1969.
EHAB vs RGR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.4M | $151.1M |
| Net Profit | $-38.7M | — |
| Gross Margin | — | 17.8% |
| Operating Margin | -12.3% | 2.3% |
| Net Margin | -14.3% | — |
| Revenue YoY | 4.7% | 3.6% |
| Net Profit YoY | 15.9% | — |
| EPS (diluted) | $-0.76 | $0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.4M | $151.1M | ||
| Q3 25 | $263.6M | $126.8M | ||
| Q2 25 | $266.1M | $132.5M | ||
| Q1 25 | $259.9M | $135.7M | ||
| Q4 24 | $258.2M | $145.8M | ||
| Q3 24 | $253.6M | $122.3M | ||
| Q2 24 | $260.6M | $130.8M | ||
| Q1 24 | $262.4M | $136.8M |
| Q4 25 | $-38.7M | — | ||
| Q3 25 | $11.1M | $1.6M | ||
| Q2 25 | $5.2M | $-17.2M | ||
| Q1 25 | $17.8M | $7.8M | ||
| Q4 24 | $-46.0M | — | ||
| Q3 24 | $-110.2M | $4.7M | ||
| Q2 24 | $-200.0K | $8.3M | ||
| Q1 24 | $200.0K | $7.1M |
| Q4 25 | — | 17.8% | ||
| Q3 25 | — | 15.1% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | — | 22.0% | ||
| Q4 24 | — | 22.8% | ||
| Q3 24 | — | 18.5% | ||
| Q2 24 | — | 22.3% | ||
| Q1 24 | — | 21.5% |
| Q4 25 | -12.3% | 2.3% | ||
| Q3 25 | 6.4% | -2.7% | ||
| Q2 25 | 6.3% | -15.6% | ||
| Q1 25 | 6.1% | 6.2% | ||
| Q4 24 | -16.0% | 7.8% | ||
| Q3 24 | -38.6% | 3.1% | ||
| Q2 24 | 4.3% | 6.9% | ||
| Q1 24 | 4.9% | 5.5% |
| Q4 25 | -14.3% | — | ||
| Q3 25 | 4.2% | 1.2% | ||
| Q2 25 | 2.0% | -13.0% | ||
| Q1 25 | 6.8% | 5.7% | ||
| Q4 24 | -17.8% | — | ||
| Q3 24 | -43.5% | 3.9% | ||
| Q2 24 | -0.1% | 6.3% | ||
| Q1 24 | 0.1% | 5.2% |
| Q4 25 | $-0.76 | $0.22 | ||
| Q3 25 | $0.22 | $0.10 | ||
| Q2 25 | $0.10 | $-1.05 | ||
| Q1 25 | $0.35 | $0.46 | ||
| Q4 24 | $-0.92 | $0.62 | ||
| Q3 24 | $-2.20 | $0.28 | ||
| Q2 24 | $0.00 | $0.47 | ||
| Q1 24 | $0.01 | $0.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $43.6M | $92.5M |
| Total DebtLower is stronger | $426.0M | — |
| Stockholders' EquityBook value | $534.0M | $283.8M |
| Total Assets | $1.2B | $342.0M |
| Debt / EquityLower = less leverage | 0.80× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $43.6M | $92.5M | ||
| Q3 25 | $56.9M | $80.8M | ||
| Q2 25 | $37.1M | $101.4M | ||
| Q1 25 | $39.5M | $108.3M | ||
| Q4 24 | $28.4M | $105.5M | ||
| Q3 24 | $45.7M | $96.0M | ||
| Q2 24 | $28.5M | $105.6M | ||
| Q1 24 | $36.5M | $115.3M |
| Q4 25 | $426.0M | — | ||
| Q3 25 | $441.5M | — | ||
| Q2 25 | $456.9M | — | ||
| Q1 25 | $467.3M | — | ||
| Q4 24 | $492.6M | — | ||
| Q3 24 | $502.9M | — | ||
| Q2 24 | $512.7M | — | ||
| Q1 24 | $526.7M | — |
| Q4 25 | $534.0M | $283.8M | ||
| Q3 25 | $566.8M | $279.6M | ||
| Q2 25 | $552.4M | $289.3M | ||
| Q1 25 | $543.2M | $321.5M | ||
| Q4 24 | $523.5M | $319.6M | ||
| Q3 24 | $566.1M | $314.9M | ||
| Q2 24 | $674.3M | $321.5M | ||
| Q1 24 | $672.3M | $332.0M |
| Q4 25 | $1.2B | $342.0M | ||
| Q3 25 | $1.2B | $342.3M | ||
| Q2 25 | $1.2B | $349.5M | ||
| Q1 25 | $1.2B | $379.0M | ||
| Q4 24 | $1.2B | $384.0M | ||
| Q3 24 | $1.3B | $373.5M | ||
| Q2 24 | $1.4B | $376.7M | ||
| Q1 24 | $1.4B | $385.0M |
| Q4 25 | 0.80× | — | ||
| Q3 25 | 0.78× | — | ||
| Q2 25 | 0.83× | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | 0.94× | — | ||
| Q3 24 | 0.89× | — | ||
| Q2 24 | 0.76× | — | ||
| Q1 24 | 0.78× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.4M | $15.5M |
| Free Cash FlowOCF − Capex | $3.3M | $12.3M |
| FCF MarginFCF / Revenue | 1.2% | 8.2% |
| Capex IntensityCapex / Revenue | 0.4% | 2.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $65.8M | $38.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.4M | $15.5M | ||
| Q3 25 | $37.8M | $12.9M | ||
| Q2 25 | $10.6M | $14.7M | ||
| Q1 25 | $17.9M | $11.1M | ||
| Q4 24 | $-4.1M | $20.0M | ||
| Q3 24 | $28.4M | $9.4M | ||
| Q2 24 | $9.6M | $18.7M | ||
| Q1 24 | $17.3M | $7.3M |
| Q4 25 | $3.3M | $12.3M | ||
| Q3 25 | $36.2M | $7.0M | ||
| Q2 25 | $8.7M | $9.1M | ||
| Q1 25 | $17.6M | $10.0M | ||
| Q4 24 | $-4.7M | $16.4M | ||
| Q3 24 | $27.7M | $2.6M | ||
| Q2 24 | $8.9M | $10.1M | ||
| Q1 24 | $15.5M | $5.6M |
| Q4 25 | 1.2% | 8.2% | ||
| Q3 25 | 13.7% | 5.5% | ||
| Q2 25 | 3.3% | 6.9% | ||
| Q1 25 | 6.8% | 7.4% | ||
| Q4 24 | -1.8% | 11.2% | ||
| Q3 24 | 10.9% | 2.1% | ||
| Q2 24 | 3.4% | 7.7% | ||
| Q1 24 | 5.9% | 4.1% |
| Q4 25 | 0.4% | 2.1% | ||
| Q3 25 | 0.6% | 4.6% | ||
| Q2 25 | 0.7% | 4.2% | ||
| Q1 25 | 0.1% | 0.8% | ||
| Q4 24 | 0.2% | 2.5% | ||
| Q3 24 | 0.3% | 5.5% | ||
| Q2 24 | 0.3% | 6.6% | ||
| Q1 24 | 0.7% | 1.3% |
| Q4 25 | — | — | ||
| Q3 25 | 3.41× | 8.15× | ||
| Q2 25 | 2.04× | — | ||
| Q1 25 | 1.01× | 1.43× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.98× | ||
| Q2 24 | — | 2.27× | ||
| Q1 24 | 86.50× | 1.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EHAB
| Third Party Payor Medicare | $111.6M | 41% |
| Third Party Payor Medicare Advantage | $67.5M | 25% |
| Hospice Segment | $63.6M | 24% |
| Third Party Payor Managed Care | $24.9M | 9% |
| Third Party Payor Medicaid | $1.7M | 1% |
RGR
| Firearms | $150.6M | 100% |
| Castings | $7.3M | 5% |
